Patent: 11,072,615
✉ Email this page to a colleague
Summary for Patent: 11,072,615
| Title: | Solid forms of a toll-like receptor modulator |
| Abstract: | The present invention provides crystalline forms, solvates and hydrates of 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one, and methods of making. |
| Inventor(s): | Brown Brandon Heath, Roethle Paul A. |
| Assignee: | GILEAD SCIENCES, INC. |
| Application Number: | US16678788 |
| Patent Claims: | see list of patent claims |
Details for Patent 11,072,615
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | May 05, 2004 | 11,072,615 | 2039-11-08 |
| Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | December 02, 2004 | 11,072,615 | 2039-11-08 |
| Amphastar Pharmaceuticals, Inc. | AMPHADASE | hyaluronidase | Injection | 021665 | October 26, 2004 | 11,072,615 | 2039-11-08 |
| Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | October 25, 2005 | 11,072,615 | 2039-11-08 |
| Merck Sharp & Dohme Llc | RECOMBIVAX, RECOMBIVAX HB | hepatitis b vaccine (recombinant) | Injection | 101066 | July 23, 1986 | 11,072,615 | 2039-11-08 |
| Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | For Injection | 103132 | June 04, 1986 | 11,072,615 | 2039-11-08 |
| Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | For Injection | 103132 | 11,072,615 | 2039-11-08 | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
